BACKGROUND: Skin-reducing mastectomy (SRM) is a method of immediate breast reconstruction derived from a Wise breast reduction incision pattern that enables immediate subpectoral implant placement after mastectomy. Its virtue lies in the manner it provides for adequate implant coverage using muscle and a deepithelialized dermal flap, thus reducing the risk of implant extrusion and providing good inframammary contour. Our experience with this technique is elaborated. METHODS: Data was collected from a prospective database in our unit from January 2006 to August 2009. Information was analyzed on indications, complications, cosmetic outcomes, and recurrence rates. RESULTS: A total of 89 SRMs were performed in 72 patients during the study period. This included 65 SRMs for invasive breast cancer, 7 for in-situ disease, and 17 for risk reduction. Median patient age was 44 years, and follow-up ranged from 5 to 42 months. Complications included capsular contracture in 14 patients, 2 implant infections, and 1 hematoma requiring surgical evacuation. Cosmetic outcomes were graded by patients as good to excellent in 66 (92%). No local recurrences have been detected to date. CONCLUSIONS: Our observations support the use of this technique as a safe, valid, and useful tool in an oncoplastic breast service.
BACKGROUND: Skin-reducing mastectomy (SRM) is a method of immediate breast reconstruction derived from a Wise breast reduction incision pattern that enables immediate subpectoral implant placement after mastectomy. Its virtue lies in the manner it provides for adequate implant coverage using muscle and a deepithelialized dermal flap, thus reducing the risk of implant extrusion and providing good inframammary contour. Our experience with this technique is elaborated. METHODS: Data was collected from a prospective database in our unit from January 2006 to August 2009. Information was analyzed on indications, complications, cosmetic outcomes, and recurrence rates. RESULTS: A total of 89 SRMs were performed in 72 patients during the study period. This included 65 SRMs for invasive breast cancer, 7 for in-situ disease, and 17 for risk reduction. Median patient age was 44 years, and follow-up ranged from 5 to 42 months. Complications included capsular contracture in 14 patients, 2 implant infections, and 1 hematoma requiring surgical evacuation. Cosmetic outcomes were graded by patients as good to excellent in 66 (92%). No local recurrences have been detected to date. CONCLUSIONS: Our observations support the use of this technique as a safe, valid, and useful tool in an oncoplastic breast service.
Authors: Luís Mata Ribeiro; Rita P Meireles; Irís M Brito; Patrícia M Costa; Marco A Rebelo; Rui F Barbosa; Miguel P Choupina; Carlos J Pinho; Matilde P Ribeiro Journal: Arch Plast Surg Date: 2022-04-06
Authors: Fabinshy Thangarajah; Timo Treeter; Barbara Krug; Martin Hellmich; Christian Eichler; Bettina Hanstein; Peter Mallmann; Wolfram Malter Journal: Breast Care (Basel) Date: 2019-02-26 Impact factor: 2.860
Authors: Selmy Awad; Ahmed Tarabay; Fahad H Qahtani; Faisal S Alsulaimani; Mohamed M Shaat; Mazin A Ali; Ahmad H Khalid; Qasem M Alharthi; Musab A ALThomali; Shabab S Althobaiti; Nadiah G AlAmri; Abdullah M Alturkistani; Abdullah A Alshamrani; Amal A Ali; Ahmed H Alsufyani; Fahad M AlSofyani; Abdullah A Alghuraybi; Amer M Alnefaie; Shuruq A Alharthi; Abdulrahman A Almalki; Abdulrahman S Alghamdi; Azzah Alzahrani; Ashraf Yehia; Mohamed Samir Abou Sheishaa Journal: BMC Surg Date: 2021-12-07 Impact factor: 2.102